Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Homogeneous Assay Measures Small Dense LDL Cholesterol

By LabMedica International staff writers
Posted on 29 Dec 2010
A simple homogeneous assay has been developed to measure plasma concentrations of small dense-low density lipoprotein (SD-LDL). More...


A rapid assay suitable for autoanalyzers has been devised to measure the concentration of SD-LDL cholesterol in blood samples and is much easier to use than the complex methods that require special equipment and long assay times.

Scientists at the Showa University School of Medicine, (Tokyo, Japan), have identified suitable surfactants and phospholipases by screening for those selective for the SD-LDL fraction (density range: 1.044 kg/L - 1.063 kg/L) and for the dissociation of other lipoproteins, including large buoyant LDL (lb-LDL). They compared this technique with ultracentrifugal isolation of LDL subfractions and with heparin-magnesium precipitation assay for SD-LDL. They measured SD-LDL-C concentrations in 460 healthy, normolipidemic individuals. Small, dense LDL is a type of LDL cholesterol that is considered to be an emerging risk factor for cardiovascular disease. It is smaller and heavier than typical LDL cholesterol and can increase the risk of developing atherosclerosis.

The homogeneous method correlated excellently with ultracentrifugation for SD-LDL-C and exhibited within-run precision. The distribution of SD-LDL-C was skewed, and the central 95% of SD-LDL-C concentrations ranged from 0.24 to 0.88 mmol/L (9.4–34.0 mg/dL). The homogeneous assay SD-LDL-C results for 60 samples from healthy volunteers were compared with those obtained by ultracentrifugation. Serum samples were obtained from these individuals who had variable serum lipid levels; LDL-C range: 1.6–5.2 mmol/L (63–199 mg/dL); triglycerides range: 0.3–5.2 mmol/L (30–472 mg/dL), and high-density lipoprotein cholesterol: 0.9–2.5 mmol/L (35–97 mg/dL).

The authors concluded that the homogeneous assay allows reproducible measurement of SD-LDL-C within 10 minutes and appears promising in further investigations of the clinical significance of SD-LDL-C. The study was published in December 2010, in Clinical Chemistry.

Related Links:

Showa University



Gold Member
Respiratory Syncytial Virus Test
OSOM® RSV Test
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Urine Chemistry Control
Dropper Urine Chemistry Control
Gel Cards
DG Gel Cards
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.